Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05998291

Dermatitis Herpetiformis Refractory to Gluten Free Diet

Gluteenittomaan Ruokavaliohoitoon Vastaamaton Ihokeliakia

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
23 (estimated)
Sponsor
Tampere University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main purpose of the study is to find out 1. the natural course of refractory dermatitis herpetiformis and the development of possible complications 2. the strictness of gluten-free diet treatment in refractory dermatitis herpetiformis

Detailed description

Refractory dermatitis herpetiformis refers to dermatitis herpetiformis unresponsive to gluten-free diet therapy. So far, there is very little knowledge on the course of the disease and the causes and prognosis of refractory celiac disease. Study patients with refractory dermatitis herpetiformis will be recruited. As a control material dermatitis herpetiformis patients with good response to gluten-free dietary treatment will be recruited.

Conditions

Interventions

TypeNameDescription
OTHERAssessment of prognosis of refractory dermatitis herpetiformis. No interventionAssessment of prognosis of refractory dermatitis herpetiformis. No intervention

Timeline

Start date
2023-06-15
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2023-08-18
Last updated
2023-08-22

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT05998291. Inclusion in this directory is not an endorsement.

Dermatitis Herpetiformis Refractory to Gluten Free Diet (NCT05998291) · Clinical Trials Directory